Dr. Joshua Richter Discusses Multiple Myeloma Clinical Trials John Theurer Cancer Center 2:01 8 years ago 227 Далее Скачать
Bispecific Antibodies | Joshua Richter, MD | ASH 2022 HealthTree Foundation for Multiple Myeloma 3:11 2 years ago 875 Далее Скачать
Cevostamab in RRMM Patients: CAMMA 2 Study Results | Joshua Richter, MD | EHA 2024 HealthTree Foundation for Multiple Myeloma 2:25 6 months ago 261 Далее Скачать
What are CELMoDs in Multiple Myeloma (& When Will They Be Available?) | Dr. Joshua Richter The Patient Story 3:04 2 years ago 328 Далее Скачать
Emerging Bispecifics Myeloma Patients Should Know About | Dr. Joshua Richter | The Patient Story The Patient Story 21:02 2 years ago 760 Далее Скачать
What Are Bispecifics in Multiple Myeloma? (For Patients and Caregivers) | Dr. Joshua Richter The Patient Story 5:20 2 years ago 424 Далее Скачать
Cevostamab, a FcRH5 bispecific antibody, for RRMM | Joshua Richter, MD | #ASH2024 HealthTree Foundation for Multiple Myeloma 3:24 2 weeks ago 179 Далее Скачать
Real-world outcomes of autoSCT for multiple myeloma in the first-line setting VJHemOnc – Video Journal of Hematology & HemOnc 2:00 2 years ago 182 Далее Скачать
T Cell Re-direction Therapy | Joshua Richter, MD | EHA 2022 HealthTree Foundation for Multiple Myeloma 2:18 2 years ago 216 Далее Скачать
Questions to Ask My Doctor about New Myeloma Treatments | Dr. Joshua Richter | The Patient Story The Patient Story 5:02 2 years ago 575 Далее Скачать
ASCO/EHA 2024 Myeloma Highlights- IMROZ, DREAMM-7, DREAMM-8 | Joshua Richter, MD | EHA 2024 HealthTree Foundation for Multiple Myeloma 2:31 6 months ago 460 Далее Скачать
Outcomes of patients with myeloma receiving fixed-duration cevostamab VJHemOnc – Video Journal of Hematology & HemOnc 1:02 2 years ago 119 Далее Скачать
Safety and efficacy of linvoseltamab for patients with R/R multiple myeloma VJHemOnc – Video Journal of Hematology & HemOnc 1:25 2 years ago 253 Далее Скачать
Safety & efficacy of cevostamab in patients with heavily pre-treated R/R multiple myeloma VJHemOnc – Video Journal of Hematology & HemOnc 2:06 1 year ago 234 Далее Скачать
Joshua Richter, MD, Talks Results from LINKER-MM1 Study Blood Cancers Today 5:08 1 year ago 154 Далее Скачать
Dr. Richter on the Importance of Optimizing Available Therapies in Multiple Myeloma OncLive 1:00 4 years ago 177 Далее Скачать
How Often Should MRD Testing Occur During Remission (and an MRD Overview) with Dr. Joshua Richter HealthTree Foundation for Multiple Myeloma 57:58 2 years ago 1 055 Далее Скачать
Myeloma Treatment: When Should a Clinical Trial Be Considered? Patient Empowerment Network 1:56 3 years ago 41 Далее Скачать
Could combinatorial CAR-T approaches lead to curative therapy for multiple myeloma? VJHemOnc – Video Journal of Hematology & HemOnc 1:49 2 years ago 137 Далее Скачать
